| Application number | Title of the application | Filing Date | Status |
|---|
| 09/409634 | SECRETED PROTEINS AND USES THEREOF | Sep 29, 1999 | Abandoned |
| 09/399723 | SECRETED PROTEINS AND USES THEREOF | Sep 19, 1999 | Abandoned |
| 09/394832 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SECRETED FRIZZLED RELATED BACKGROUND OF THE INVENTION PROTEIN | Sep 12, 1999 | Abandoned |
Array
(
[id] => 1479461
[patent_doc_number] => 06451977
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Fused polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/392277
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 86
[patent_no_of_words] => 67044
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451977.pdf
[firstpage_image] =>[orig_patent_app_number] => 09392277
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/392277 | Fused polypeptides | Sep 2, 1999 | Issued |
| 09/382918 | 15625 RECEPTOR, A NOVEL G-PROTEIN COUPLED RECEPTOR | Aug 24, 1999 | Abandoned |
Array
(
[id] => 6716658
[patent_doc_number] => 20030028006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'CYTOKINE RECEPTOR COMMON GAMMA CHAIN LIKE'
[patent_app_type] => new
[patent_app_number] => 09/376430
[patent_app_country] => US
[patent_app_date] => 1999-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 88206
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20030028006.pdf
[firstpage_image] =>[orig_patent_app_number] => 09376430
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/376430 | Cytokine receptor common gamma chain like | Aug 17, 1999 | Issued |
Array
(
[id] => 1316367
[patent_doc_number] => 06605278
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-12
[patent_title] => 'Uses of trank, a novel secretory cytokine'
[patent_app_type] => B1
[patent_app_number] => 09/375907
[patent_app_country] => US
[patent_app_date] => 1999-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 6663
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/605/06605278.pdf
[firstpage_image] =>[orig_patent_app_number] => 09375907
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/375907 | Uses of trank, a novel secretory cytokine | Aug 16, 1999 | Issued |
Array
(
[id] => 4246042
[patent_doc_number] => 06221660
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'DNA encoding SNORF25 receptor'
[patent_app_type] => 1
[patent_app_number] => 9/387699
[patent_app_country] => US
[patent_app_date] => 1999-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 26242
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221660.pdf
[firstpage_image] =>[orig_patent_app_number] => 387699
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/387699 | DNA encoding SNORF25 receptor | Aug 12, 1999 | Issued |
| 09/370684 | DEXTRAN-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS | Aug 8, 1999 | Abandoned |
Array
(
[id] => 682431
[patent_doc_number] => 07081360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-25
[patent_title] => 'Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties'
[patent_app_type] => utility
[patent_app_number] => 09/362286
[patent_app_country] => US
[patent_app_date] => 1999-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29395
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/081/07081360.pdf
[firstpage_image] =>[orig_patent_app_number] => 09362286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/362286 | Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties | Jul 26, 1999 | Issued |
| 09/351777 | MAMMALIAN GENES; RELATED REAGENTS | Jul 11, 1999 | Abandoned |
Array
(
[id] => 1469584
[patent_doc_number] => 06406884
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Secreted proteins and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/336536
[patent_app_country] => US
[patent_app_date] => 1999-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 78
[patent_no_of_words] => 51579
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/406/06406884.pdf
[firstpage_image] =>[orig_patent_app_number] => 09336536
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/336536 | Secreted proteins and uses thereof | Jun 17, 1999 | Issued |
| 09/327807 | MELANIN CONCENTRATING HORMONE RECEPTOR | Jun 7, 1999 | Abandoned |
Array
(
[id] => 4268490
[patent_doc_number] => 06306820
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Combination therapy using a TNF binding protein for treating TNF-mediated diseases'
[patent_app_type] => 1
[patent_app_number] => 9/326394
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23905
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306820.pdf
[firstpage_image] =>[orig_patent_app_number] => 326394
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/326394 | Combination therapy using a TNF binding protein for treating TNF-mediated diseases | Jun 3, 1999 | Issued |
Array
(
[id] => 1546408
[patent_doc_number] => 06444793
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Hydrophobically-modified hedgehog protein compositions and methods'
[patent_app_type] => B1
[patent_app_number] => 09/325256
[patent_app_country] => US
[patent_app_date] => 1999-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 53047
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444793.pdf
[firstpage_image] =>[orig_patent_app_number] => 09325256
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/325256 | Hydrophobically-modified hedgehog protein compositions and methods | Jun 2, 1999 | Issued |
| 09/321683 | DNA ENCODING ORPHAN SNORF44 RECEPTOR | May 27, 1999 | Abandoned |
Array
(
[id] => 1286760
[patent_doc_number] => 06635431
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications'
[patent_app_type] => B1
[patent_app_number] => 09/269939
[patent_app_country] => US
[patent_app_date] => 1999-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 62
[patent_no_of_words] => 63558
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635431.pdf
[firstpage_image] =>[orig_patent_app_number] => 09269939
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269939 | LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications | May 27, 1999 | Issued |
Array
(
[id] => 5888548
[patent_doc_number] => 20020012962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'RECEPTOR BASED ANTAGONISTS AND METHODS OF MAKING AND USING'
[patent_app_type] => new
[patent_app_number] => 09/313942
[patent_app_country] => US
[patent_app_date] => 1999-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 18311
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20020012962.pdf
[firstpage_image] =>[orig_patent_app_number] => 09313942
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/313942 | Receptor based antagonists and methods of making and using | May 18, 1999 | Issued |
Array
(
[id] => 1542262
[patent_doc_number] => 06372494
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Methods of making conditioned cell culture medium compositions'
[patent_app_type] => B1
[patent_app_number] => 09/313538
[patent_app_country] => US
[patent_app_date] => 1999-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17380
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09313538
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/313538 | Methods of making conditioned cell culture medium compositions | May 13, 1999 | Issued |
| 09/312359 | SECRETED PROTEINS AND USES THEREOF | May 13, 1999 | Abandoned |
